Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
12.06
+0.01 (0.08%)
Nov 13, 2026, 4:00 PM EST

Knight Therapeutics Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
563.45450.09371.3328.2293.56243.48
Revenue Growth
36.15%21.22%13.13%11.80%20.57%22.03%
Cost of Revenue
291.57249.86196.9175.55155.5128.07
Gross Profit
271.88200.23174.41152.65138.06115.41
Selling, General & Admin
144.83124.1199.3583.6988.6274.38
Research & Development
38.9828.9823.317.5514.7612.69
Amortization of Goodwill & Intangibles
56.7849.4944.3645.0451.7441.18
Operating Expenses
240.59202.58167.01146.28155.12128.24
Operating Income
31.29-2.357.46.37-17.06-12.83
Interest Expense
-10.7-10.42-9.22-12.49-6.6-3.62
Interest & Investment Income
4.256.2110.4112.5810.637.38
Currency Exchange Gain (Loss)
0.21.86-4.19-15.177.44-3.74
Other Non Operating Income (Expenses)
4.48-2.270.2312.3-22.6819.07
EBT Excluding Unusual Items
29.53-6.984.623.58-28.276.27
Gain (Loss) on Sale of Investments
-0.62-2.34-11.79-19.62--
Asset Writedown
----9.26-23.98-
Other Unusual Items
-10.472.629.233.38.290.42
Pretax Income
18.44-6.72.05-21.99-43.966.69
Income Tax Expense
2.46-1.33-2.28-5.15-14.07-8.99
Earnings From Continuing Operations
15.98-5.374.33-16.84-29.8915.68
Net Income
15.98-5.374.33-16.84-29.8915.68
Net Income to Common
15.98-5.374.33-16.84-29.8915.68
Net Income Growth
------62.74%
Shares Outstanding (Basic)
99100101107115124
Shares Outstanding (Diluted)
100100101107115125
Shares Change
-0.34%-1.84%-5.61%-6.46%-7.74%-5.66%
EPS (Basic)
0.16-0.050.04-0.16-0.260.13
EPS (Diluted)
0.16-0.050.04-0.16-0.260.13
EPS Growth
------60.55%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
126.3867.0533.8134.9942.1240.79
Free Cash Flow Per Share
1.270.670.330.330.370.33
Gross Margin
48.25%44.49%46.97%46.51%47.03%47.40%
Operating Margin
5.55%-0.52%1.99%1.94%-5.81%-5.27%
Profit Margin
2.84%-1.19%1.17%-5.13%-10.18%6.44%
Free Cash Flow Margin
22.43%14.90%9.11%10.66%14.35%16.75%
EBITDA
88.9149.455.9653.2640.9832.46
EBITDA Margin
15.78%10.98%15.07%16.23%13.96%13.33%
D&A For EBITDA
57.6251.7548.5646.8958.0445.29
EBIT
31.29-2.357.46.37-17.06-12.83
EBIT Margin
5.55%-0.52%1.99%1.94%-5.81%-5.27%
Effective Tax Rate
13.33%-----